Natera NTRA Stock
Natera Price Chart
Natera NTRA Financial and Trading Overview
| Natera stock price | 235.15 USD |
| Previous Close | 231.41 USD |
| Open | 231.52 USD |
| Bid | 209.19 USD x 200 |
| Ask | 239.95 USD x 200 |
| Day's Range | 219.58 - 234.14 USD |
| 52 Week Range | 131.81 - 256.36 USD |
| Volume | 1.58M USD |
| Avg. Volume | 1.41M USD |
| Market Cap | 32.77B USD |
| Beta (5Y Monthly) | 1.544 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.62 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 260.05 USD |
NTRA Valuation Measures
| Enterprise Value | 32.29B USD |
| Trailing P/E | N/A |
| Forward P/E | -1097.994 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 13.102213 |
| Price/Book (mrq) | 18.408562 |
| Enterprise Value/Revenue | 12.913 |
| Enterprise Value/EBITDA | -120.689 |
Trading Information
Natera Stock Price History
| Beta (5Y Monthly) | 1.544 |
| 52-Week Change | 35.82% |
| S&P500 52-Week Change | 24.48% |
| 52 Week High | 256.36 USD |
| 52 Week Low | 131.81 USD |
| 50-Day Moving Average | 207.88 USD |
| 200-Day Moving Average | 206.57 USD |
NTRA Share Statistics
| Avg. Volume (3 month) | 1.41M USD |
| Avg. Daily Volume (10-Days) | 1.26M USD |
| Shares Outstanding | 143.22M |
| Float | 138.91M |
| Short Ratio | 2.06 |
| % Held by Insiders | 3.01% |
| % Held by Institutions | 96.09% |
| Shares Short | 3.61M |
| Short % of Float | 2.59% |
| Short % of Shares Outstanding | 2.52% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -9.048% |
| Operating Margin (ttm) | -12.39% |
| Gross Margin | 65.06% |
| EBITDA Margin | -10.69% |
Management Effectiveness
| Return on Assets (ttm) | -9.11% |
| Return on Equity (ttm) | -15.018% |
Income Statement
| Revenue (ttm) | 2.5B USD |
| Revenue Per Share (ttm) | 18.07 USD |
| Quarterly Revenue Growth (yoy) | 38.80% |
| Gross Profit (ttm) | 1.63B USD |
| EBITDA | -267576992 USD |
| Net Income Avi to Common (ttm) | -226315008 USD |
| Diluted EPS (ttm) | -1.62 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.09B USD |
| Total Cash Per Share (mrq) | 7.6 USD |
| Total Debt (mrq) | 240.08M USD |
| Total Debt/Equity (mrq) | 13.53 USD |
| Current Ratio (mrq) | 2.959 |
| Book Value Per Share (mrq) | 12.429 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 211.02M USD |
| Levered Free Cash Flow (ttm) | 136.92M USD |
Profile of Natera
| Country | United States |
| State | TX |
| City | Austin |
| Address | 13011 McCallen Pass |
| ZIP | 78753 |
| Phone | 650 980 9190 |
| Website | https://www.natera.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 6135 |
Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients previously diagnosed with cancer; Latitude, a blood-based MRD test for colorectal cancer; Altera, a tissue based comprehensive genomic profiling test; and Empower, a hereditary cancer screening test. The company also provides Panorama, a non-invasive prenatal test; Horizon, a carrier screening test; Fetal Focus, a single-gene NIPT, or sgNIPT, that screens for 21 single-gene inherited conditions; and Vistara, a single-gene NIPT, which screens for 25 single-gene conditions. In addition, it offers Anora, which tests and analyzes miscarriage tissue from women who have experienced one or more pregnancy losses; Empower, a hereditary cancer screening test; Prospera, a test to assess active rejection in patients who have undergone solid organ transplantation; Renasight, a kidney gene panel test; and Constellation software, a cloud-based distribution model. Further, the company provides NateraCore, a platform to support the patient and provider experience; phlebotomy services; and EMR integration services. The company serves independent laboratories, national and regional reference laboratories, medical centers and physician practices for its screening tests, research laboratories, and pharmaceutical companies through its direct sales force and laboratory distribution partners, as well as Constellation licensees under its cloud-based distribution model. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays for clinical and commercial use. The company has a collaboration with Diakonos Oncology Corp. to assess molecular response in patients with refractory melanoma. The company was formerly known as Gene Security Network, LLC and changed its name to Natera, Inc. in January 2012. Natera, Inc. was founded in 2003 and is headquartered in Austin, Texas.
Q&A For Natera Stock
What is a current NTRA stock price?
Natera NTRA stock price today per share is 235.15 USD.
How to purchase Natera stock?
You can buy NTRA shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Natera?
The stock symbol or ticker of Natera is NTRA.
Which industry does the Natera company belong to?
The Natera industry is Diagnostics & Research.
How many shares does Natera have in circulation?
The max supply of Natera shares is 143.22M.
What is Natera Price to Earnings Ratio (PE Ratio)?
Natera PE Ratio is now.
What was Natera earnings per share over the trailing 12 months (TTM)?
Natera EPS is -1.62 USD over the trailing 12 months.
Which sector does the Natera company belong to?
The Natera sector is Healthcare.
Natera NTRA included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25775.82 USD — |
-1.49
|
4.19B USD — | 25513.26 USD — | 25882.57 USD — | — - | 4.19B USD — |
US Tech Global Select Market Com
NQGS
US
|
12635.82 USD — |
-1.55
|
— — | 12513.27 USD — | 12692.24 USD — | — - | — — |
US Tech DM Ex Japan Large Mid Ca
NQDMXJPLMAUD
US
|
2100.38 AUD 1467.26 USD |
<0.01
|
— — | 2100.38 AUD 1467.26 USD | 2100.38 AUD 1467.26 USD | — - | — — |
US Tech Health Care
IXHC
US
|
1187.28 USD — |
+0.97
|
— — | 1174.72 USD — | 1190.38 USD — | — - | — — |
US Tech Composite Total Return
XCMP
US
|
31781.81 USD — |
-1.53
|
— — | 31469.2 USD — | 31924.72 USD — | — - | — — |
US Tech AlphaDEX Multi Cap Growt
NQDXUSMLTCG
US
|
4131.98 USD — |
-2.14
|
— — | 4089.8 USD — | 4163.55 USD — | — - | — — |
- {{ link.label }} {{link}}


